Ind-Swift Laboratories Share Price
Know More₹110.60 9.45 (9.34%)
02:29 PM, 16-Jan-2026₹110.06 9.34 (9.27%)
02:19 PM, 16-Jan-2026BSE : 532305
NSE : INDSWFTLAB
Sector : Health care
ISIN Code : INE915B01019
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 16-Jan-2026 | 02:29 PM IST
| Market Cap (₹ Cr) | 903 |
Traded Value (₹ Cr) | 0.37 |
Volume (Shares) | 33,258 |
Face Value (₹) | 10 |
52-Week High (₹) | 124.45 |
52-Week High Date | 08-Jul-2025 |
52-Week Low (₹) | 67.15 |
52-Week Low Date | 09-May-2025 |
All Time High (₹) | 297.35 |
All Time High Date | 22-Dec-2004 |
All Time Low (₹) | 13.25 |
All Time Low Date | 31-Mar-2003 |
Ind-Swift Laboratories Ltd
Market News
Ind-Swift Labs. Announcement
Ind-Swift Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 895 |
| EPS - TTM (₹) [C] | 28.62 |
| P/E Ratio (X) [C] | 3.83 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 20-Sep-2011 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 160.21 |
| P/B Ratio (₹) [C] | 0.68 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 343 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 98.68 111.75 |
| Week Low/High (₹) | 89.00 111.75 |
| Month Low/High (₹) | 87.15 111.75 |
| Year Low/High (₹) | 68.72 124.00 |
| All time Low/High (₹) | 13.25 297.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 20.89% | 15.89% | -0.03% | -0.01% |
| 1 Month | 15.21% | 9.76% | -1.33% | -0.69% |
| 3 Month | 4.42% | 0.11% | 0.10% | 0.37% |
| 6 Month | 3.69% | -0.71% | 1.11% | 1.86% |
| 1 Year | 3.15% | 0.16% | 8.45% | 10.16% |
| 3 Year | 66.51% | 59.16% | 39.03% | 43.51% |
Company Info
Company Information
Chairman & Managing Director : N R Munjal
Joint Managing Director : Himanshu Jain
Company Sec. & Compli. Officer : Pradeep Verma
Executive Director : Rishav Mehta
Independent Director : S P Sharma
Independent Director : Neerja Chathley
Independent Director : Ashwani K Vig
Executive Director : Sahil Munjal
Independent Director : Rajendra Kumar Gupta
Independent Director : Param Bir Singh
Registered Office: SCO 850 Shivalik Enclave, NAC Manimajra,Chandigarh,Chandigarh-160101 Ph: 91-0172-5061850/2730920
FAQs about Ind-Swift Laboratories Ltd
1. What's the Ind-Swift Laboratories Ltd share price today?
Ind-Swift Laboratories Ltd share price was Rs 110.60 at 02:29 PM IST on 16th Jan 2026. Ind-Swift Laboratories Ltd share price was up by 9.34% over the previous closing price of Rs 101.15. Ind-Swift Laboratories Ltd share price trend:
- Last 1 Month: Ind-Swift Laboratories Ltd share price moved up by 15.21% on BSE.
- Last 3 Months: Ind-Swift Laboratories Ltd share price moved up by 4.42% on BSE.
- Last 12 Months: Ind-Swift Laboratories Ltd share price moved up by 3.15% on BSE.
- Last 3 Years: Ind-Swift Laboratories Ltd share price moved up by 66.51% on BSE.
2. How can I quickly analyse the performance of the Ind-Swift Laboratories Ltd stock?
The performance of the Ind-Swift Laboratories Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 3.83
- Price to book value ratio is 0.68
- The EPS (trailing 12 months) of the Ind-Swift Laboratories Ltd stock is Rs 28.62
3. What is the market cap of Ind-Swift Laboratories Ltd?
Ind-Swift Laboratories Ltd has a market capitalisation of Rs 903 crore.
4. What is Ind-Swift Laboratories Ltd's 52-week high/low share price?
The Ind-Swift Laboratories Ltd’s 52-week high share price is Rs 124.45 and 52-week low share price is Rs 67.15.
5. Is the Ind-Swift Laboratories Ltd profitable?
On a consolidated basis, Ind-Swift Laboratories Ltd reported a profit of Rs 8.04 crore on a total income of Rs 170.50 crore for the quarter ended 2025.
6. Which are Ind-Swift Laboratories Ltd’s peers in the Health care sector?
Ind-Swift Laboratories Ltd’s top 5 peers in the Health care sector are Venus Remedies, Fermenta Biotec., Lincoln Pharma., Ind-Swift Labs., NGL Fine Chem, Titan Biotech, Themis Medicare.
7. Who owns how much in Ind-Swift Laboratories Ltd?
Key changes to the Ind-Swift Laboratories Ltd shareholding are as follows:
- Promoter holding in Ind-Swift Laboratories Ltd has gone up to 39.50 per cent as of Sep 2025 from 36.77 per cent as of Jul 2025.